New chemo formula aims to keep lung cancer away after surgery
Disease control
Recruiting now
This study tests a drug called SMS001, a new version of the chemotherapy paclitaxel, in 42 people with non-small cell lung cancer (stages Ib to IIIa). The goal is to see if a single dose after surgery can safely prevent the cancer from coming back. Researchers will monitor side e…
Phase: PHASE2 • Sponsor: ToLymph Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC